Yahoo News | PRWeb
GIA announces the release of a comprehensive global report on Organ and Tissue Transplantationmarkets. The global market for Organ and Tissue Transplantation is forecast to reach 114 Thousand Procedures by the year 2017. Key factors driving the need for organ transplantations include increasing graying population, and escalating incidence of organ failure cases due to fatal diseases. In addition, advancements in technology, surgical techniques, and immunosuppressive drugs are also propelling the market for organ transplants.
San Jose, California (PRWEB) February 23, 2012
Buoyed by advancements in technology, surgical techniques and immunosuppressive drugs, organ transplantation has become the preferred treatment for several chronic diseases pertaining to heart, kidneys, lungs, pancreas, and liver. Advancements in organ and tissue transplantation have phenomenally revolutionized the quality of life and survival rate across terminal conditions. While a tissue transfer enhances the quality of life of a patient, organ transfer saves or enhances the lives of patients suffering from organ failures. Organ transplantation has increasingly become a pivotal intervention for thousands of patients suffering from fatal end-stage diseases. Several policies guide transplantations around the world, and there exists various possibilities to procure as well as allocate organs for transplantation.